Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Fatma Aydogan"'
Publikováno v:
Molecular and Clinical Oncology. 3:954-958
Breast cancer is a complex disease displaying different profiles involving genetic as well as epigenetic factors. MicroRNAs (miRNAs) are small, non-coding RNAs that regulate gene expression. Recent studies demonstrated that miRNAs may display great p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8561c8509e82254cbed1d62061311df7
https://doi.org/10.3892/mco.2015.567
https://doi.org/10.3892/mco.2015.567
Autor:
Ibrahim Yildiz, Leyla Kilic, Faruk Aykan, Fatma Aydogan, Serkan Keskin, Fatma Sen, Sezer Saglam, Meltem Ekenel, Burak Sakar, Rian Disci
Publikováno v:
Clinical and Translational Oncology. 15:403-408
The aim of this retrospective study (from January 2007 to December 2011) was to investigate the efficacy and tolerability of mDCF schedule for chemotherapy-naïve AGC patients.Patients (n = 54) with locally inoperable or distant metastasis and perfor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df94a6b4f83b8decda5cbe9f4d69a856
https://doi.org/10.1007/s12094-012-0942-8
https://doi.org/10.1007/s12094-012-0942-8
Autor:
Murat Emin Guveli, Mahmut Muslumanoglu, Fatma Aydogan, Erkan Topuz, Vahit Ozmen, Yesim Eralp, Abdullah Igci, Adnan Aydiner, Pinar Saip, Serkan Keskin, Esmehan Pehlivan, Ekrem Yavuz, Hasan Karanlik
Publikováno v:
Oncology. 81(1)
Objective: Patients with breast cancer with a pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) have a better prognosis than patients with residual disease. The aim of the current study was to identify predictors of pCR. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a9be73e8e736f92517b7e37697b44ca
https://pubmed.ncbi.nlm.nih.gov/21912195
https://pubmed.ncbi.nlm.nih.gov/21912195
Autor:
Halil Alis, Sezai Vatansever, Mehmet Karabulut, Senem Karabulut, Nuri Faruk Aykan, Koray Celebi, Hamza Ugur Bozbey, Kayhan Erturk, Fatma Aydogan
Publikováno v:
Journal of Clinical Oncology. 33:e14533-e14533
e14533 Background: Claudin-7 (CLDN7) belongs to the claudin family which consists of 24 subtypes of essential tight junction integral membrane proteins with molecular weights of 20-27 kDa. Tight ju...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3996eb0991eb1d287ae2c3e4886c5a38
https://doi.org/10.1200/jco.2015.33.15_suppl.e14533
https://doi.org/10.1200/jco.2015.33.15_suppl.e14533
Autor:
Sezer Saglam, Leyla Kilic, Meltem Ekenel, Burak Sakar, Serkan Keskin, Rian Disci, Faruk Aykan, Fatma Sen, Fatma Aydogan
Publikováno v:
Journal of Clinical Oncology. 30:e14628-e14628
e14628 Background: The aim of this retrospective study (from January 2007 to December 2011) was to investigate the efficacy and tolerability of mDCF schedule for chemotherapy naïve AGC patients. Methods: Patients (n=54) with locally inoperable or di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b46c474d28eefb98cc1367a059fccf2
https://doi.org/10.1200/jco.2012.30.15_suppl.e14628
https://doi.org/10.1200/jco.2012.30.15_suppl.e14628
Autor:
Fatma Aydogan, Faruk Tas, Mehmet Karabulut, Cigdem Usul Afsar, Senem Karabulut, Halil Alis, Mehmet Abdussamet Bozkurt, Murat Serilmez
Publikováno v:
BBA Clinical
Background Omentin is related with metabolic syndrome and obesity. Pancreatic adenocarcinoma (PA) is a lethal and obesity-linked malignancy. This study was conducted to investigate the serum levels of omentin in patients with PA and the relationship
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba3b7aa6c0888e84c14d1b2e1761b6fe
